This page provides a roundup of resources relating to innovations in treatments, vaccines, and technology:
Recent announcements on vaccine developments - Updated Feb 26, 2021:
AstraZeneca COVID-19 Vaccine has been granted interim authorization by Health Canada for active immunization of individuals 18 years of age and older for the prevention of coronavirus disease 2019 (PDF). - Feb 26, 2021
|Moderna's mRNA-127||Press release on COVID-19 Vaccine Supply Update - Jan 4, 2021|
|Johnson & Johnson's JNJ-78436735 (Ad26.COV2.S)||Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial - Jan 29, 2021|
The COVID-19 coronavirus has had a widespread global economic impact. You may be wondering how your company, industry, and market may be impacted -- and how the market research you are reading may need to be updated. This page details the updates we have collected from market research vendors available to you via U of T Libraries, as well as other sources available online.
This page will be updated regularly as the situation develops.
UTL databases (access here)
Open online sources (access via web browser)
Andressen Horowitz has compiled a collection of Coronavirus resources and readings for VCs and startups.
McKinsey has created a collection of resources titled Coronavirus: Leading through the Crisis
Not available via UTL, Pitchbook has also analyzed the impact on private markets.
U of T Entrepreneurship has a list of COVID-19 resources for startups.
Women Entrepreneurship Knowledge Hub has compiled a list of resources for Canadian entrepreneurs.
Gerstein Science Information Centre
9 King's College Circle
Toronto, ON, M5S 1A5
About web accessibility. Tell us about a web accessibility problem.
About online privacy and data collection.
© University of Toronto. All rights reserved.